EP2667851 - TESTOSTERONE FORMULATIONS [Right-click to bookmark this link] | Status | Opposition rejected Status updated on 03.12.2021 Database last updated on 03.04.2025 | |
Former | The patent has been granted Status updated on 12.11.2018 | Most recent event Tooltip | 03.12.2021 | Opposition rejected | published on 05.01.2022 [2022/01] | Applicant(s) | For all designated states Ferring BV Polaris Avenue 144 2132 JX Hoofddorp / NL | [2013/49] | Inventor(s) | 01 /
GRENIER, Arnaud 6 rue des Bergers F-68440 Steinbrunn le Haut / FR | 02 /
CARRARA, Dario, N. Storchenweg 3 CH-4104 Oberwil / CH | [2013/49] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2016/20] |
Former [2013/49] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE | Application number, filing date | 12700406.7 | 18.01.2012 | [2016/20] | WO2012EP50695 | Priority number, date | EP20110152210 | 26.01.2011 Original published format: EP 11152210 | US201161436207P | 26.01.2011 Original published format: US 201161436207 P | [2013/49] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2012101016 | Date: | 02.08.2012 | Language: | EN | [2012/31] | Type: | A1 Application with search report | No.: | EP2667851 | Date: | 04.12.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.08.2012 takes the place of the publication of the European patent application. | [2013/49] | Type: | B1 Patent specification | No.: | EP2667851 | Date: | 18.05.2016 | Language: | EN | [2016/20] | Search report(s) | International search report - published on: | EP | 02.08.2012 | Classification | IPC: | A61K9/06, A61K47/10, A61P5/26, A61K31/568, A61K31/58, A61K9/00 | [2013/49] | CPC: |
A61K31/568 (EP,KR,RU,US);
A61K9/06 (KR,RU);
A61K31/58 (EP,RU,US);
A61K47/10 (EP,KR,RU,US);
A61K47/18 (US);
A61K47/32 (RU,US);
A61K9/0014 (EP,RU,US);
A61K9/10 (KR);
A61K9/107 (KR);
A61K9/70 (RU);
A61P15/00 (EP);
A61P15/08 (EP);
A61P15/10 (EP);
A61P19/10 (EP);
A61P21/00 (EP);
A61P25/24 (EP);
A61P3/02 (EP);
A61P5/00 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/49] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | TESTOSTERONFORMULIERUNGEN | [2013/49] | English: | TESTOSTERONE FORMULATIONS | [2013/49] | French: | FORMULATIONS DE TESTOSTÉRONE | [2013/49] | Entry into regional phase | 26.07.2013 | National basic fee paid | 26.07.2013 | Designation fee(s) paid | 26.07.2013 | Examination fee paid | Examination procedure | 26.07.2013 | Examination requested [2013/49] | 23.12.2013 | Amendment by applicant (claims and/or description) | 02.03.2015 | Despatch of a communication from the examining division (Time limit: M04) | 19.03.2015 | Reply to a communication from the examining division | 23.07.2015 | Despatch of a communication from the examining division (Time limit: M02) | 27.07.2015 | Reply to a communication from the examining division | 02.12.2015 | Communication of intention to grant the patent | 23.03.2016 | Fee for grant paid | 23.03.2016 | Fee for publishing/printing paid | 23.03.2016 | Receipt of the translation of the claim(s) | Divisional application(s) | EP16169138.1 / EP3072505 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 02.03.2015 | Opposition(s) | Opponent(s) | 01
17.02.2017
23.02.2017
ADMISSIBLE Müller Fottner Steinecke Rechtsanwalts- und Patentanwaltspartnerschaft mbB P.O. Box 11 40 Römerstrasse 16b 52428 Jülich / DE Opponent's representative Witthoff Jaekel Steinecke Patentanwälte PartG mbB, et al, et al Postfach 1140 52412 Jülich / DE | [2020/19] |
Former [2017/13] | |||
Opponent(s) | 01
17.02.2017
23.02.2017
ADMISSIBLE Müller Fottner Steinecke Rechtsanwalts- und Patentanwaltspartnerschaft mbB P.O. Box 11 40 Römerstrasse 16b 52428 Jülich / DE Opponent's representative Steinecke, Peter, et al, et al Müller Fottner Steinecke Rechtsanwalts- und Patentanwaltspartnerschaft mbB P.O. Box 1140 52412 Jülich / DE | 20.04.2017 | Invitation to proprietor to file observations on the notice of opposition | 30.10.2017 | Reply of patent proprietor to notice(s) of opposition | 10.10.2018 | Date of oral proceedings | 13.11.2018 | Despatch of minutes of oral proceedings | 13.11.2018 | Date of despatch of rejection of opposition | 26.11.2021 | Legal effect of rejection of opposition [2022/01] | Appeal following opposition | 22.01.2019 | Appeal received No. T0280/19 | 22.03.2019 | Statement of grounds filed | 16.11.2021 | Result of appeal procedure: appeal of the opponent was rejected | 19.11.2021 | Despatch of the decision of the Board of Appeal | Fees paid | Renewal fee | 21.01.2014 | Renewal fee patent year 03 | 13.01.2015 | Renewal fee patent year 04 | 11.01.2016 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CY | 18.05.2016 | MC | 18.05.2016 | MK | 18.05.2016 | SM | 18.05.2016 | MT | 18.01.2017 | [2019/51] |
Former [2019/46] | CY | 18.05.2016 | |
MC | 18.05.2016 | ||
SM | 18.05.2016 | ||
MT | 18.01.2017 | ||
Former [2018/43] | MC | 18.05.2016 | |
SM | 18.05.2016 | ||
MT | 18.01.2017 | ||
Former [2017/47] | MC | 18.05.2016 | |
SM | 18.05.2016 | ||
Former [2017/13] | SM | 18.05.2016 | Cited in | International search | [XAI]WO2004080413 (ANTARES PHARMA IPL AG [CH], et al) | by applicant | US7198801 |